Lutetium Lu 177 Dotatate Patent Expiration
Lutetium Lu 177 Dotatate was first introduced by Advanced Accelerator Applications Usa Inc
Lutetium Lu 177 Dotatate Patents
Given below is the list of patents protecting Lutetium Lu 177 Dotatate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Lutathera |
US10596276 (Pediatric) | Stable, concentrated radionuclide complex solutions | Jan 25, 2039 | Aaa Usa Inc |
| Lutathera |
US10596278 (Pediatric) | Stable, concentrated radionuclide complex solutions | Jan 25, 2039 | Aaa Usa Inc |
| Lutathera |
US11904027 (Pediatric) | Stable, concentrated radionuclide complex solutions | Jan 25, 2039 | Aaa Usa Inc |
| Lutathera | US10596276 | Stable, concentrated radionuclide complex solutions | Jul 25, 2038 | Aaa Usa Inc |
| Lutathera | US10596278 | Stable, concentrated radionuclide complex solutions | Jul 25, 2038 | Aaa Usa Inc |
| Lutathera | US11904027 | Stable, concentrated radionuclide complex solutions | Jul 25, 2038 | Aaa Usa Inc |
Lutetium Lu 177 Dotatate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List